This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA). The $8,003.82 firm-fixed-price delivery order is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a diabetes medication. The contract has an ultimate completion date of June 9, 2025 and is not set aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $11,608.10. It was issued by the Defense Logistics Agency (DLA) for the procurement of the pharmaceutical product OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The contract has a firm fixed price pricing type and an ultimate completion date of July 12, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,218.43 firm fixed-price delivery order is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a pharmaceutical product. The contract has an ultimate completion date of August 14, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract as well as other Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corporation's Corporate Office Division a $7,256.75 firm-fixed-price delivery order contract for the pharmaceutical product OZEMPIC 1MG/0.75ML. This order was placed under Amerisourcebergen's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical and medical supplies to DLA facilities...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,817.11 Firm Fixed Price Delivery Order contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a prescription medication. The contract has an ultimate completion date of February 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) is a Delivery Order valued at $1,161.08 for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, placed by the Defense Logistics Agency (DLA). The contract has a period of performance through November 7, 2024 and utilizes a Firm Fixed Price pricing type. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,888.99 firm fixed-price delivery order contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a diabetes medication. The contract has an ultimate completion date of December 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,428.94 firm fixed-price delivery order is for the pharmaceutical product OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The contract has an ultimate completion date of March 25, 2025 and is not designated as a set-aside requirement. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,879.98 firm fixed-price delivery order is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a diabetes medication. The contract has an ultimate completion date of May 14, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,350.56, is a Firm Fixed Price Delivery Order for the medical product "OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML". The contract has an ultimate completion date of November 18, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that...